10.1016/s0031-9422(00)00103-5 11 ChoiS
Last year, Hims & Hers, another direct-to-consumer telehealth provider, ran its first Super Bowl ad pushing for greater access to weight loss drugs
Improved Metabolic Health: Semaglutide supports better blood sugar control and can reduce the risk of developing metabolic syndrome
Clinical Evidence for Weight Loss and Metabolic Health A Phase 2 trial published in NEJM (2023) reported approximately 24.2% mean body weight reduction over 48 weeks at the highest dose, alongside improvements in fasting glucose, insulin sensitivity, triglycerides, and waist circumference
Your prescriber will need to attest that you met the clinical criteria when you first started the medication
Treatments are provided under the supervision of licensed medical providers